Clinical Report: Expanding CGM Access for Medicare Patients
Overview
A quality improvement initiative at a diabetes clinic significantly increased continuous glucose monitoring (CGM) adoption among Medicare patients treated with insulin, following expanded Medicare coverage. The project demonstrated that structured interventions can effectively translate policy changes into improved patient access.
Background
The expansion of CGM coverage by the Centers for Medicare & Medicaid Services in 2023 is crucial as it addresses a significant barrier to access for insulin-treated diabetes patients. With CGM linked to better glycemic control and reduced hypoglycemia, understanding how to implement these changes in clinical practice is essential for optimizing patient outcomes. This initiative highlights the importance of targeted interventions to ensure equitable access to diabetes management technologies.
Data Highlights
| Measure | Baseline | Post-Intervention |
|---|---|---|
| CGM Adoption Rate | 49.6% | 62.6% |
| Eligible Patients | 847 | N/A |
Key Findings
- CGM adoption among eligible Medicare patients increased from 49.6% to 62.6% after targeted interventions.
- Interventions included provider education, patient outreach, and educational materials in multiple languages.
- No significant differences in CGM use were observed based on race, ethnicity, language, income, or education.
- Lower CGM use was noted among patients not connected to the electronic health record patient portal, indicating potential digital health literacy issues.
- Older adults may face unique barriers to adopting diabetes technologies, suggesting a need for tailored interventions.
Clinical Implications
Healthcare providers should implement structured quality improvement strategies that combine education and patient engagement to enhance CGM access. Addressing digital health literacy and ensuring equitable access for all demographic groups will be critical in optimizing diabetes management.
Conclusion
The findings underscore the effectiveness of targeted clinic interventions in translating policy changes into practice, ultimately improving CGM access for Medicare patients. Future efforts should focus on expanding access in primary care settings.
Related Resources & Content
- American Diabetes Association, Standards of Care in Diabetes, 2026 -- Clinical Guidelines
- JAMA Network, Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin, 2025 -- Randomized Clinical Trial
- ophthalmology management — Coding & Reimbursement: Navigating New Coverage Challenges for MIGS
- Glaucoma Physician — Coding: Medicare Coverage of MIGS
- Ophthalmology Management — Coding & Reimbursement: Navigating New Coverage Challenges for MIGS
- Ophthalmology Management — Coding & Reimbursement Recommendations
- Standards of Care in Diabetes | ADA Clinical Guidelines
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial | Diabetes | JAMA | JAMA Network
- Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position | Diabetes Therapy | Springer Nature Link
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
